At a glance
- Originator Novartis
- Class Antirheumatics; Small molecules; Thiazolidinediones
- Mechanism of Action Retinoic acid receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 06 Oct 2006 Discontinued - Preclinical for Rheumatoid arthritis in Switzerland (unspecified route)
- 15 Nov 1996 Preclinical development for Rheumatoid arthritis in Switzerland (Unknown route)